Related Experiment Video
Updated: Jan 19, 2026

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
[Controlled sclerosing in the treatment of venous maxillofacial malformations]
A A Grishin1, O S Durdyev2, M V Smyslenova2
1First Moscow State Medical University named after I.M. Sechenov, Moscow, Russia.
Abstract:
The aim of the study was to assess the effectiveness of ultrasound-guided use of the foam form of ethoxysclerol for the treatment of venous malformations of the maxillofacial area. The study involved clinical and ultrasound examination data of 60 patient allowing to determine treatment tactics and optimal volume of injected foam sclerosant as well as the role of ultrasound for monitoring of the treatment. The results proved the efficacy of 3% foam ethoxysclerol for less invasive treatment of venous maxillofacial malformations.
Related Concept Videos
06:51A Patient-Derived Xenograft Model for Venous Malformation
Open Surgical Resection of Cerebral Arteriovenous Malformations
14:58Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
02:42Analysis of Craniomaxillofacial Malformations in Mice Using Three-dimensional Microcomputed Tomography
03:06Combination of High Ligation and Intraoperative Embolization Using Polidocanol for Treatment of Varicoceles
04:57Controlled Reversible Visceral Arterial Ischemia, Venous Congestion and Combined Malperfusion via Midline Laparotomy in Rats
